Symbols / AZTA Stock $25.91 +3.19% Azenta, Inc.

Healthcare • Medical Instruments & Supplies • United States • NMS
AZTA (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Medical Instruments & Supplies
CEO Mr. John P. Marotta
Exch · Country NMS · United States
Market Cap 1.19B
Enterprise Value 838.26M
Income 26.34M
Sales 595.03M
FCF (ttm) 108.52M
Book/sh 37.26
Cash/sh 8.89
Employees 3,000
Insider 10d —
IPO Feb 02, 1995
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E 44.67
Forward P/E 23.55
PEG 0.53
P/S 2.01
P/B 0.70
P/C —
EV/EBITDA 22.46
EV/Sales 1.41
Quick Ratio 2.23
Current Ratio 2.92
Debt/Eq 3.18
LT Debt/Eq —
EPS (ttm) 0.58
EPS next Y 1.10
EPS Growth —
Revenue Growth 0.80%
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2026-05-06
Earnings (prior) 2026-02-04
ROA -0.59%
ROE 1.53%
ROIC —
Gross Margin 44.56%
Oper. Margin -4.10%
Profit Margin -10.12%
Shs Outstand 46.06M
Shs Float 40.65M
Insider Own 0.92%
Instit Own 118.89%
Short Float 18.88%
Short Ratio 5.51
Short Interest 5.52M
52W High 41.73
vs 52W High -37.91%
52W Low 19.87
vs 52W Low 30.40%
Beta 1.47
Impl. Vol. 39.79%
Rel Volume 0.87
Avg Volume 951.24K
Volume 825.20K
Target (mean) $35.40
Tgt Median $35.00
Tgt Low $30.00
Tgt High $44.00
# Analysts 5
Recom Buy
Prev Close $25.11
Price $25.91
Change 3.19%
About

Azenta, Inc. provides biological and chemical compound sample exploration and management solutions for the life sciences industry in the United States, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. It operates through Sample Management Solutions and Multiomics segments. The Sample Management Solutions segment provides sample management products and services, including automated stores, cryogenic systems, automated sample tubes, consumables and instruments, and controlled rate thawing devices, as well as sample repository services. This segment also offers consultation services to clients throughout their experimental design and implementation processes. The Multiomics segment provides genomic and other sample analysis services comprising gene sequencing, gene synthesis, and related services. The company has a strategic partnership with Frontier Space Ltd to conduct scientific experiments in space. The company was formerly known as Brooks Automation, Inc. and changed its name to Azenta, Inc. in December 2021. Azenta, Inc. was founded in 1978 and is headquartered in Burlington, Massachusetts.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$35.40
Mean price target
2. Current target
$25.91
Latest analyst target
3. DCF / Fair value
$42.41
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$25.91
Low
$30.00
High
$44.00
Mean
$35.40

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-04-06 main Evercore ISI Group Outperform → Outperform $35
2026-03-17 reit Needham Buy → Buy $44
2026-02-05 main Evercore ISI Group Outperform → Outperform $45
2026-02-04 main Jefferies Buy → Buy $40
2026-02-04 reit Needham Buy → Buy $44
2026-01-08 main TD Cowen Hold → Hold $39
2026-01-05 up Evercore ISI Group In-Line → Outperform $50
2025-12-19 main Needham Buy → Buy $44
2025-11-25 main Raymond James Outperform → Outperform $45
2025-11-21 main Needham Buy → Buy $42
2025-10-30 up Jefferies Hold → Buy $38
2025-08-06 up Raymond James Market Perform → Outperform $35
2025-08-05 main Evercore ISI Group In-Line → In-Line $33
2025-07-08 main Evercore ISI Group In-Line → In-Line $35
2025-05-07 main Needham Buy → Buy $40
2025-02-06 main Evercore ISI Group In-Line → In-Line $52
2025-02-06 main Needham Buy → Buy $59
2025-01-02 reit Stephens & Co. Overweight → Overweight $60
2024-12-18 up Stephens & Co. Equal-Weight → Overweight $60
2024-11-13 main Needham Buy → Buy $55
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-02-06 NOVA TINA SUSAN Director — 5,663 $27.85 $157,715
2026-02-05 DOSHI DIPAL Director — 5,663 $27.85 $157,715
2026-02-05 MCLAUGHLIN ERICA Director — 5,663 $27.85 $157,715
2026-02-05 CASAL FRANK Director — 7,243 $27.85 $201,718
2025-11-24 MAROTTA JOHN Chief Executive Officer — 122,269 $0.00 $0
2025-11-24 MAROTTA JOHN Chief Executive Officer — 118,194 $0.00 $0
2025-11-24 ZHOU GINGER Officer — 13,042 $0.00 $0
2025-11-24 PIROGOVA OLGA Officer — 16,303 $0.00 $0
2025-11-24 LIN LAWRENCE Y Chief Financial Officer — 36,681 $0.00 $0
2025-11-24 STARR EPHRAIM General Counsel — 34,235 $0.00 $0
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-09-30 2024-09-30 2023-09-30 2022-09-30
Total Revenue
593.82
+3.55%
573.45
+3.98%
551.49
-0.72%
555.50
Operating Revenue
593.82
+3.55%
573.45
+3.98%
551.49
-0.72%
555.50
Cost Of Revenue
323.54
+1.48%
318.83
+2.10%
312.28
+4.12%
299.91
Reconciled Cost Of Revenue
323.54
+1.48%
318.83
+2.10%
312.28
+4.12%
299.91
Gross Profit
270.28
+6.15%
254.62
+6.44%
239.21
-6.41%
255.58
Operating Expense
291.95
-0.86%
294.48
-0.47%
295.88
+6.05%
279.01
Research And Development
30.39
-3.60%
31.52
-1.92%
32.14
+16.70%
27.54
Selling General And Administration
261.56
-0.53%
262.96
-0.30%
263.74
+4.88%
251.47
Total Expenses
615.49
+0.36%
613.31
+0.85%
608.15
+5.05%
578.92
Operating Income
-21.67
+45.63%
-39.86
+29.66%
-56.67
-141.94%
-23.42
Total Operating Income As Reported
-26.84
+47.66%
-51.28
+16.27%
-61.25
-147.61%
-24.73
EBITDA
39.54
-22.30%
50.88
+75.98%
28.91
-4.50%
30.28
Normalized EBITDA
44.71
-28.25%
62.31
+86.04%
33.49
+6.02%
31.59
Reconciled Depreciation
61.21
-32.55%
90.74
+6.03%
85.58
+59.37%
53.70
EBIT
-21.67
+45.63%
-39.86
+29.66%
-56.67
-141.94%
-23.42
Total Unusual Items
-5.17
+54.74%
-11.42
-149.60%
-4.58
-248.86%
-1.31
Total Unusual Items Excluding Goodwill
-5.17
+54.74%
-11.42
-149.60%
-4.58
-248.86%
-1.31
Special Income Charges
-5.17
+54.74%
-11.42
-149.60%
-4.58
-248.86%
-1.31
Other Special Charges
—
—
—
0.63
Impairment Of Capital Assets
0.00
-100.00%
4.66
0.00
0.00
Restructuring And Mergern Acquisition
5.17
-23.57%
6.77
+47.83%
4.58
+248.86%
1.31
Net Income
-55.76
+66.18%
-164.90
-1026.65%
-14.64
-100.69%
2,132.86
Pretax Income
-7.14
+62.65%
-19.12
+4.40%
-20.00
-101.34%
-9.94
Net Non Operating Interest Income Expense
18.78
-42.91%
32.89
-24.46%
43.54
+177.38%
15.70
Interest Expense Non Operating
—
—
0.00
-100.00%
4.59
Net Interest Income
18.78
-42.91%
32.89
-24.46%
43.54
+177.38%
15.70
Interest Expense
—
—
0.00
-100.00%
4.59
Interest Income Non Operating
18.78
-42.91%
32.89
-24.46%
43.54
+177.38%
15.70
Interest Income
18.78
-42.91%
32.89
-24.46%
43.54
+177.38%
15.70
Other Income Expense
-4.25
+65.05%
-12.16
-76.76%
-6.88
-211.18%
-2.21
Other Non Operating Income Expenses
0.92
+225.96%
-0.73
+68.17%
-2.30
-156.12%
-0.90
Tax Provision
-31.60
-702.96%
5.24
+143.80%
-11.96
-986.30%
1.35
Tax Rate For Calcs
0.00
+0.00%
0.00
+0.00%
0.00
+0.00%
0.00
Tax Effect Of Unusual Items
-1.09
+54.74%
-2.40
-149.60%
-0.96
-248.86%
-0.28
Net Income Including Noncontrolling Interests
-55.76
+66.18%
-164.90
-1026.65%
-14.64
-100.69%
2,132.86
Net Income From Continuing Operation Net Minority Interest
24.46
+200.38%
-24.37
-203.06%
-8.04
+28.76%
-11.29
Net Income From Continuing And Discontinued Operation
-55.76
+66.18%
-164.90
-1026.65%
-14.64
-100.69%
2,132.86
Net Income Continuous Operations
24.46
+200.38%
-24.37
-203.06%
-8.04
+28.76%
-11.29
Net Income Discontinuous Operations
-80.22
+42.92%
-140.53
-2030.55%
-6.60
-100.31%
2,144.14
Normalized Income
28.54
+286.06%
-15.34
-246.76%
-4.42
+56.84%
-10.25
Net Income Common Stockholders
-55.76
+66.18%
-164.90
-1026.65%
-14.64
-100.69%
2,132.86
Diluted EPS
-1.30
+63.91%
-3.60
-1537.54%
-0.22
-100.77%
28.48
Basic EPS
-1.30
+63.91%
-3.60
-1537.54%
-0.22
-100.77%
28.48
Basic Average Shares
45.74
+0.38%
45.57
-31.22%
66.25
-11.54%
74.90
Diluted Average Shares
45.90
+0.72%
45.57
-31.22%
66.25
-11.54%
74.90
Diluted NI Availto Com Stockholders
-55.76
+66.18%
-164.90
-1026.65%
-14.64
-100.69%
2,132.86
Line Item Trend 2025-09-30 2024-09-30 2023-09-30 2022-09-30
Total Assets
2,059.58
-1.94%
2,100.26
-27.22%
2,885.72
-22.35%
3,716.12
Current Assets
708.34
-14.97%
833.03
-41.29%
1,418.96
-42.30%
2,459.35
Cash Cash Equivalents And Short Term Investments
340.92
-20.94%
431.19
-57.63%
1,017.78
-35.17%
1,570.04
Cash And Cash Equivalents
279.78
-0.09%
280.03
-58.75%
678.91
+3.13%
658.27
Other Short Term Investments
61.14
-59.56%
151.16
-55.39%
338.87
-62.83%
911.76
Receivables
151.91
-14.68%
178.04
+13.74%
156.53
-4.41%
163.76
Accounts Receivable
142.18
-7.78%
154.17
-1.51%
156.53
-4.41%
163.76
Gross Accounts Receivable
146.83
-7.96%
159.52
-3.08%
164.59
-2.56%
168.92
Allowance For Doubtful Accounts Receivable
-4.65
+13.09%
-5.35
+33.61%
-8.06
-56.08%
-5.16
Taxes Receivable
9.73
-59.24%
23.87
—
—
Inventory
74.96
+5.10%
71.32
-44.37%
128.20
+49.86%
85.54
Raw Materials
33.32
+21.33%
27.46
-54.13%
59.86
+50.84%
39.69
Work In Process
5.05
-34.75%
7.74
-32.11%
11.40
+136.71%
4.82
Finished Goods
36.59
+1.29%
36.12
-36.56%
56.94
+38.73%
41.04
Prepaid Assets
—
—
—
132.62
Restricted Cash
2.36
+14.02%
2.07
-55.51%
4.65
-98.78%
382.60
Assets Held For Sale Current
73.53
-25.76%
99.05
—
0.00
Hedging Assets Current
—
0.00
-100.00%
13.04
-89.55%
124.79
Other Current Assets
64.66
+25.90%
51.36
-47.99%
98.75
-25.54%
132.62
Total Non Current Assets
1,351.24
+6.63%
1,267.23
-13.60%
1,466.76
+16.71%
1,256.78
Net PPE
208.00
-3.72%
216.03
-20.67%
272.32
+76.30%
154.47
Gross PPE
374.01
+4.43%
358.15
-7.50%
387.20
+62.34%
238.52
Accumulated Depreciation
-166.01
-16.81%
-142.12
-23.72%
-114.88
-36.68%
-84.05
Properties
0.00
0.00
0.00
0.00
Buildings And Improvements
33.99
+3.29%
32.91
-21.41%
41.87
+41.54%
29.58
Machinery Furniture Equipment
202.34
+18.49%
170.76
-8.90%
187.45
+41.66%
132.32
Construction In Progress
22.39
-24.25%
29.55
-12.86%
33.91
-7.45%
36.64
Other Properties
54.05
-16.82%
64.98
-8.87%
71.30
+2779.56%
2.48
Leases
61.24
+2.15%
59.95
+13.82%
52.67
+40.47%
37.49
Goodwill And Other Intangible Assets
804.21
-1.50%
816.45
-24.31%
1,078.64
+55.87%
692.02
Goodwill
702.39
+1.59%
691.41
-11.85%
784.34
+52.71%
513.62
Other Intangible Assets
101.81
-18.58%
125.04
-57.51%
294.30
+64.97%
178.40
Investments And Advances
201.59
+307.62%
49.45
-55.58%
111.34
-68.37%
352.02
Non Current Accounts Receivable
45.60
—
—
—
Non Current Deferred Assets
0.73
-13.26%
0.84
+46.58%
0.57
-51.15%
1.17
Non Current Deferred Taxes Assets
0.73
-13.26%
0.84
+46.58%
0.57
-51.15%
1.17
Other Non Current Assets
91.12
-50.60%
184.46
+4640.79%
3.89
-93.18%
57.09
Total Liabilities Net Minority Interest
332.60
+0.05%
332.42
-5.35%
351.22
-0.43%
352.74
Current Liabilities
237.67
+15.33%
206.09
-2.29%
210.93
-8.51%
230.55
Payables And Accrued Expenses
82.12
-10.83%
92.09
-26.15%
124.70
-7.94%
135.45
Payables
47.14
+11.10%
42.43
-33.46%
63.77
-23.62%
83.49
Accounts Payable
37.72
+13.13%
33.34
-6.85%
35.80
-7.39%
38.65
Current Accrued Expenses
34.98
-29.56%
49.66
-18.49%
60.93
+17.25%
51.96
Employee Benefits
—
—
—
0.26
Pensionand Other Post Retirement Benefit Plans Current
35.80
+22.53%
29.22
-13.85%
33.91
-19.06%
41.90
Total Tax Payable
9.42
+3.64%
9.09
-67.52%
27.97
-37.61%
44.84
Income Tax Payable
9.42
+3.64%
9.09
+23.14%
7.38
-74.04%
28.42
Current Deferred Liabilities
58.07
+9.94%
52.82
+0.95%
52.32
-1.64%
53.20
Current Deferred Revenue
58.07
+9.94%
52.82
+0.95%
52.32
-1.64%
53.20
Other Current Liabilities
61.69
+92.99%
31.96
—
—
Total Non Current Liabilities Net Minority Interest
94.92
-24.86%
126.33
-9.95%
140.29
+14.81%
122.19
Liabilities Heldfor Sale Non Current
14.29
-66.13%
42.20
—
0.00
Long Term Debt And Capital Lease Obligation
51.24
-9.59%
56.68
-6.22%
60.44
+22.77%
49.23
Long Term Debt
—
—
—
—
Long Term Capital Lease Obligation
51.24
-9.59%
56.68
-6.22%
60.44
+22.77%
49.23
Non Current Pension And Other Postretirement Benefit Plans
—
—
—
0.26
Non Current Deferred Liabilities
18.25
+0.34%
18.18
-73.13%
67.68
+2.18%
66.24
Non Current Deferred Taxes Liabilities
18.25
+0.34%
18.18
-73.13%
67.68
+2.18%
66.24
Other Non Current Liabilities
11.14
+20.17%
9.27
-23.84%
12.18
+81.07%
6.72
Stockholders Equity
1,726.99
-2.31%
1,767.85
-30.25%
2,534.50
-24.64%
3,363.39
Common Stock Equity
1,726.99
-2.31%
1,767.85
-30.25%
2,534.50
-24.64%
3,363.39
Capital Stock
0.59
+0.68%
0.59
-17.25%
0.71
-19.44%
0.89
Common Stock
0.59
+0.68%
0.59
-17.25%
0.71
-19.44%
0.89
Preferred Stock
0.00
0.00
0.00
0.00
Share Issued
59.32
+0.49%
59.03
-17.20%
71.29
-19.43%
88.48
Ordinary Shares Number
45.86
+0.63%
45.57
-21.20%
57.83
-22.91%
75.02
Treasury Shares Number
13.46
+0.00%
13.46
+0.00%
13.46
+0.00%
13.46
Additional Paid In Capital
529.61
+4.67%
505.96
-56.24%
1,156.16
-41.96%
1,992.02
Retained Earnings
1,419.96
-3.78%
1,475.72
-10.07%
1,641.01
-0.87%
1,655.36
Gains Losses Not Affecting Retained Earnings
-22.21
-64.98%
-13.46
+78.43%
-62.43
+25.61%
-83.92
Treasury Stock
200.96
+0.00%
200.96
+0.00%
200.96
+0.00%
200.96
Other Equity Adjustments
-22.21
-64.98%
-13.46
+78.43%
-62.43
+25.61%
-83.92
Total Equity Gross Minority Interest
1,726.99
-2.31%
1,767.85
-30.25%
2,534.50
-24.64%
3,363.39
Total Capitalization
1,726.99
-2.31%
1,767.85
-30.25%
2,534.50
-24.64%
3,363.39
Working Capital
470.67
-24.93%
626.94
-48.10%
1,208.03
-45.80%
2,228.80
Invested Capital
1,726.99
-2.31%
1,767.85
-30.25%
2,534.50
-24.64%
3,363.39
Total Debt
51.24
-9.59%
56.68
-6.22%
60.44
+22.77%
49.23
Capital Lease Obligations
51.24
-9.59%
56.68
-6.22%
60.44
+22.77%
49.23
Net Tangible Assets
922.78
-3.01%
951.40
-34.65%
1,455.86
-45.50%
2,671.36
Tangible Book Value
922.78
-3.01%
951.40
-34.65%
1,455.86
-45.50%
2,671.36
Available For Sale Securities
201.59
+307.62%
49.45
-55.58%
111.34
-68.37%
352.02
Investmentin Financial Assets
201.59
+307.62%
49.45
-55.58%
111.34
-68.37%
352.02
Line Item Trend 2025-09-30 2024-09-30 2023-09-30 2022-09-30
Operating Cash Flow
72.18
+45.11%
49.74
+752.64%
5.83
+101.25%
-466.05
Cash Flow From Continuing Operating Activities
72.18
+45.11%
49.74
+752.64%
5.83
+101.25%
-466.05
Net Income From Continuing Operations
-55.76
+66.18%
-164.90
-1026.65%
-14.64
-100.69%
2,132.86
Depreciation Amortization Depletion
61.21
-32.55%
90.74
+6.03%
85.58
+59.37%
53.70
Depreciation And Amortization
61.21
-32.55%
90.74
+6.03%
85.58
+59.37%
53.70
Other Non Cash Items
—
4.32
+148.59%
-8.88
+82.87%
-51.86
Stock Based Compensation
20.88
+44.34%
14.47
+54.30%
9.38
-12.09%
10.67
Asset Impairment Charge
3.48
-97.19%
123.69
0.00
0.00
Deferred Tax
-27.04
-70.20%
-15.89
+44.73%
-28.74
-217.45%
24.47
Deferred Income Tax
-27.04
-70.20%
-15.89
+44.73%
-28.74
-217.45%
24.47
Operating Gains Losses
93.83
+31598.99%
0.30
+588.37%
0.04
+100.00%
-2,129.65
Gain Loss On Sale Of PPE
0.71
+140.20%
0.30
+588.37%
0.04
+304.76%
-0.02
Change In Working Capital
-22.84
-851.46%
3.04
+110.47%
-29.04
+60.08%
-72.73
Change In Receivables
-24.56
-103.54%
-12.07
-135.02%
34.46
+209.74%
-31.40
Changes In Account Receivables
21.04
+274.35%
-12.07
-135.02%
34.46
+209.74%
-31.40
Change In Inventory
-2.67
-116.80%
15.90
+92.61%
8.25
+112.39%
-66.63
Change In Prepaid Assets
—
—
—
—
Change In Payables And Accrued Expense
8.03
+39.44%
5.76
+119.72%
-29.20
-475.34%
7.78
Change In Accrued Expense
6.99
+303.37%
-3.44
+76.28%
-14.49
-223.81%
11.71
Change In Payable
1.04
-88.72%
9.20
+162.52%
-14.71
-274.68%
-3.93
Change In Account Payable
1.04
-88.72%
9.20
+162.52%
-14.71
-274.68%
-3.93
Change In Other Working Capital
-3.63
+44.50%
-6.55
+84.61%
-42.54
-342.93%
17.51
Investing Cash Flow
-90.46
-140.25%
224.74
-47.90%
431.38
-70.57%
1,465.59
Cash Flow From Continuing Investing Activities
-90.46
-140.25%
224.74
-47.90%
431.38
-70.57%
1,465.59
Net PPE Purchase And Sale
-33.86
+9.45%
-37.39
+5.18%
-39.44
+46.30%
-73.44
Purchase Of PPE
-33.86
+9.45%
-37.39
+5.18%
-39.44
+46.30%
-73.44
Capital Expenditure
-33.86
+9.45%
-37.39
+5.18%
-39.44
+49.07%
-77.44
Net Investment Purchase And Sale
-56.60
-121.59%
262.13
-69.42%
857.33
+167.49%
-1,270.21
Purchase Of Investment
-451.41
-11.30%
-405.57
-71.71%
-236.19
+88.04%
-1,975.60
Sale Of Investment
394.81
-40.87%
667.71
-38.94%
1,093.52
+55.03%
705.38
Net Business Purchase And Sale
0.00
0.00
+100.00%
-386.51
-113.74%
2,813.24
Purchase Of Business
0.00
0.00
+100.00%
-386.51
-207.05%
-125.88
Gain Loss On Sale Of Business
—
0.00
0.00
+100.00%
-2,130.26
Net Intangibles Purchase And Sale
—
0.00
0.00
+100.00%
-4.00
Purchase Of Intangibles
—
0.00
0.00
+100.00%
-4.00
Net Other Investing Changes
—
—
—
—
Financing Cash Flow
-9.59
+98.55%
-659.21
+21.57%
-840.46
-1239.12%
-62.76
Cash Flow From Continuing Financing Activities
-9.59
+98.55%
-659.21
+21.57%
-840.46
-1239.12%
-62.76
Net Issuance Payments Of Debt
-0.98
-25.80%
-0.78
-35.47%
-0.58
+98.85%
-50.11
Issuance Of Debt
—
—
—
—
Repayment Of Debt
-0.98
-25.80%
-0.78
-35.47%
-0.58
+98.85%
-50.11
Long Term Debt Issuance
—
—
—
—
Long Term Debt Payments
-0.98
-25.80%
-0.78
-35.47%
-0.58
+98.85%
-50.11
Net Long Term Debt Issuance
-0.98
-25.80%
-0.78
-35.47%
-0.58
+98.85%
-50.11
Net Common Stock Issuance
2.77
+100.42%
-658.42
+21.14%
-834.89
-16017.88%
5.25
Common Stock Payments
0.00
+100.00%
-661.70
+21.09%
-838.51
0.00
Common Stock Dividend Paid
—
0.00
0.00
+100.00%
-7.49
Cash Dividends Paid
—
0.00
0.00
+100.00%
-7.49
Repurchase Of Capital Stock
0.00
+100.00%
-661.70
+21.09%
-838.51
0.00
Net Other Financing Charges
-11.38
—
-4.99
+52.04%
-10.40
Changes In Cash
-27.87
+92.76%
-384.73
+4.59%
-403.24
-143.05%
936.78
Effect Of Exchange Rate Changes
3.57
-83.54%
21.67
-52.88%
45.99
+125.43%
-180.82
Beginning Cash Position
320.99
-53.07%
684.04
-34.31%
1,041.30
+264.94%
285.33
End Cash Position
296.69
-7.57%
320.99
-53.07%
684.04
-34.31%
1,041.30
Free Cash Flow
38.32
+210.29%
12.35
+136.76%
-33.60
+93.82%
-543.48
Interest Paid Supplemental Data
—
0.00
0.00
-100.00%
0.47
Income Tax Paid Supplemental Data
6.57
+142.90%
2.70
-93.72%
43.07
-90.48%
452.46
Amortization Of Securities
-1.58
+73.84%
-6.03
+23.35%
-7.87
-315.52%
-1.89
Common Stock Issuance
2.77
-15.52%
3.28
-9.44%
3.62
-30.96%
5.25
Earnings Losses From Equity Investments
—
—
—
—
Issuance Of Capital Stock
2.77
-15.52%
3.28
-9.44%
3.62
-30.96%
5.25
Sale Of Business
—
0.00
0.00
-100.00%
2,939.12
Taxes Refund Paid
—
0.00
0.00
+100.00%
-431.60
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category